Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma—A Romanian Perspective

Background: Asthma is the most common chronic disease affecting children, with a negative impact on their quality of life. Asthma is often associated with comorbid allergic diseases, and its severity may be modulated by immunoglobulin E (IgE)-mediated allergen sensitization. Omalizumab is a humanize...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghea, Elena Camelia, Balgradean, Mihaela, Pavelescu, Carmen, Cirstoveanu, Catalin Gabriel, Toma, Claudia Lucia, Ionescu, Marcela Daniela, Bumbacea, Roxana Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700741/
https://www.ncbi.nlm.nih.gov/pubmed/34943337
http://dx.doi.org/10.3390/children8121141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700741/
https://www.ncbi.nlm.nih.gov/pubmed/34943337
http://dx.doi.org/10.3390/children8121141

Ejemplares similares